This modified UTP N1-Methylpseudouridine-5'-Triphosphate can replace UTP in in-vitro-transcription reactions, e.g. for manufacturing mRNA therapeutics and vaccines. The RNA modification provides enhanced protein expression and has been used to reduce unwanted immunogenicity against the mRNA molecule itself.
We are continuously expanding our portfolio of fit-for-purpose reagents and N1-Methyl-Pseudo-UTP, GMP Grade, AOF is the latest addition to the family in GMP Grade.
View product details and order information